Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
21.11.24
/
50%
€44.00
Target price
21.11.25
€96.83
Performance (%)
-34.09%
End price
22.11.25
€29.00
Summary
This prediction ended on 22.11.25 with a price of €29.00. The BUY prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc. performed very badly with a performance of -34.09%. JPMorgan_Chase___Co_ has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.290% | -1.290% | -28.837% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at JPMorgan Chase & Co. from $105.00 to $102.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
27.03.25
27.03.25
€108.68
27.03.26
27.03.26
-16.11%
07:33
07:33
Stopped prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€81.12
27.02.25
27.02.25
-17.74%
28.02.25
28.02.25